Fig. 7From: RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors a Effect of RRx-001 (ABDNAZ) treatment on blood flow and tissue hypoxia in U87 tumors. b Comparison of RRx-001 effect on tumor architecture, blood flow, and hypoxia in U87 tumorBack to article page